Christopher Cimarusti Board of Director Membership

Home

Insights

Christopher Cimarusti Board Membership

Last Updated on: Nov 23, 2024

About Christopher Cimarusti

Dr. Christopher Cimarusti, aged 79, holds a Ph.D. in Organic Chemistry from Purdue University and completed post-doctoral research at Columbia University.
With over 50 years of experience in the pharmaceutical industry, he has been instrumental in drug discovery, development, and manufacturing, contributing to more than 60 patents and over 40 published papers.
He provides consulting services to Neuland Laboratories, particularly in reviewing R&D activities and developing strategic action plans for the R&D team.
His extensive background includes senior roles at Glaxo India and various academic research positions, and he is a member of the Royal Society of Chemistry.
His expertise is highly valued by the Board of Directors, who recognized the benefits of his re-appointment at their meeting on May 11, 2023.

List of Companies Associated with Christopher Cimarusti

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Neuland Laboratories Ltd

Non Executive Director

16077.07

Pharmaceuticals

Mar, 2024

Company Name	Position Held
Neuland Laboratories Ltd	Non Executive Director

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Christopher Cimarusti at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Christopher Cimarusti depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Christopher Cimarusti is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Christopher Cimarusti Sector Specific Experience

About Christopher Cimarusti's work experience

Christopher Cimarusti is currently a Non Executive Director in Neuland Laboratories Ltd (as of Mar 2024).
Christopher Cimarusti is serving the company - Neuland Laboratories Ltd at this position since 2024 for the last 1+ years.
Prior to becoming Non Executive Director, Christopher Cimarusti was Director of Neuland Laboratories Ltd for 9 years from 2015 to 2023.

FAQ's related Christopher Cimarusti

Who is Christopher Cimarusti

Dr. Christopher Cimarusti, aged 79, holds a Ph.D. in Organic Chemistry from Purdue University and completed post-doctoral research at Columbia University. With over 50 years of experience in the pharmaceutical industry, he has been instrumental in drug discovery, development, and manufacturing, contributing to more than 60 patents and over 40 published papers. He provides consulting services to Neuland Laboratories, particularly in reviewing R&D activities and developing strategic action plans for the R&D team. His extensive background includes senior roles at Glaxo India and various academic research positions, and he is a member of the Royal Society of Chemistry. His expertise is highly valued by the Board of Directors, who recognized the benefits of his re-appointment at their meeting on May 11, 2023.

Which companies does Christopher Cimarusti serve as a board member for?

Christopher Cimarusti serves as a board member for: Neuland Laboratories Ltd

What positions has Christopher Cimarusti held in his/her career?

Throughout their career, Christopher Cimarusti has held key positions such as Non Executive Director,Director, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*